Display options
Cite
Thakolwiboon S, Zhu J, Liang Q, et al. Heterogeneity of The CD90. J Proteomics Bioinform. 2014;7(10):296-302doi: 10.4172/jpb.1000332.
Thakolwiboon, S., Zhu, J., Liang, Q., Welling, T. H., Zhang, M., & Lubman, D. M. (2014). Heterogeneity of The CD90. Journal of proteomics & bioinformatics, 7(10), 296-302. https://doi.org/10.4172/jpb.1000332
Thakolwiboon, Smathorn, et al. "Heterogeneity of The CD90." Journal of proteomics & bioinformatics vol. 7,10 (2014): 296-302. doi: https://doi.org/10.4172/jpb.1000332
Thakolwiboon S, Zhu J, Liang Q, Welling TH, Zhang M, Lubman DM. Heterogeneity of The CD90. J Proteomics Bioinform. 2014 Sep 12;7(10):296-302. doi: 10.4172/jpb.1000332. PMID: 25580065; PMCID: PMC4285360.
Copy Download .nbib Format: NLM
Share it on

J Proteomics Bioinform. 2014 Sep 12;7(10):296-302. doi: 10.4172/jpb.1000332.

Heterogeneity of The CD90.

Journal of proteomics & bioinformatics

Smathorn Thakolwiboon, Jianhui Zhu, Qixing Liang, Theodore H Welling, Min Zhang, David M Lubman

Affiliations

  1. Department of Surgery, University of Michigan Medical Center, Ann Arbor, Michigan 48109, United States ; Department of Medicine, Faculty of Medicine Siriraj hospital, Mahidol University, Bangkok10700, Thailand.
  2. Department of Surgery, University of Michigan Medical Center, Ann Arbor, Michigan 48109, United States.
  3. Department of Biostatistics, University of Michigan School of Public Health, Ann Arbor, Michigan 48109, United States.

PMID: 25580065 PMCID: PMC4285360 DOI: 10.4172/jpb.1000332

Abstract

We have characterized herein the heterogeneity of the CD90

Keywords: CD90; Cancer stem cell; Hepatocarcinogenesis; Hepatocellular carcinoma; Immunohistochemistry; Thy-1

References

  1. PLoS One. 2013;8(3):e57020 - PubMed
  2. Gastroenterology. 2007 Jun;132(7):2542-56 - PubMed
  3. Mol Cell Proteomics. 2012 Jun;11(6):M111.010744 - PubMed
  4. World J Gastroenterol. 2014 Feb 28;20(8):2098-106 - PubMed
  5. Oncotarget. 2013 Jan;4(1):106-17 - PubMed
  6. Cancer Res. 2013 Apr 1;73(7):2322-32 - PubMed
  7. PLoS One. 2012;7(5):e37159 - PubMed
  8. Mod Pathol. 2010 Oct;23(10):1346-56 - PubMed
  9. Oncogene. 2012 Feb 9;31(6):671-82 - PubMed
  10. Gut. 2008 Aug;57(8):1129-38 - PubMed
  11. Stem Cells Dev. 2011 Dec;20(12):2023-30 - PubMed
  12. Oncol Rep. 2013 Dec;30(6):2733-40 - PubMed
  13. Am J Pathol. 2013 Jan;182(1):266-76 - PubMed
  14. Childs Nerv Syst. 2013 Apr;29(4):549-63 - PubMed
  15. Hepatology. 2013 Apr;57(4):1484-97 - PubMed
  16. Biochem Biophys Res Commun. 2006 Dec 29;351(4):820-4 - PubMed
  17. FASEB J. 2006 Jun;20(8):1045-54 - PubMed
  18. Immunology. 1983 Jul;49(3):555-64 - PubMed
  19. PLoS One. 2013 Nov 13;8(11):e78885 - PubMed
  20. Int J Hepatol. 2011;2011:120925 - PubMed
  21. Therap Adv Gastroenterol. 2010 Jan;3(1):55-66 - PubMed
  22. Expert Rev Anticancer Ther. 2013 Apr;13(4):469-79 - PubMed
  23. J Invest Dermatol. 2013 Sep;133(9):2255-64 - PubMed
  24. Semin Liver Dis. 2005;25(2):212-25 - PubMed
  25. J Immunol. 2012 Feb 1;188(3):981-91 - PubMed
  26. Acta Histochem. 2011 Dec;113(8):833-8 - PubMed
  27. Nat Rev Cancer. 2012 Nov;12 (11):767-75 - PubMed
  28. Circ Res. 1998 May 4;82(8):845-51 - PubMed
  29. Immunol Cell Biol. 1997 Oct;75(5):430-45 - PubMed
  30. Int J Cancer. 2007 Apr 1;120(7):1444-50 - PubMed
  31. Exp Cell Res. 2010 Oct 15;316(17):2982-92 - PubMed
  32. Cancer Cell. 2008 Feb;13(2):153-66 - PubMed
  33. Cold Spring Harb Perspect Med. 2012 Mar;2(3):a006536 - PubMed
  34. BMC Cancer. 2008 Jan 29;8:28 - PubMed
  35. Microvasc Res. 2002 Jul;64(1):86-93 - PubMed
  36. Cell Stem Cell. 2011 Jul 8;9(1):50-63 - PubMed
  37. Stem Cells Dev. 2011 Dec;20(12):2177-88 - PubMed
  38. N Engl J Med. 2011 Sep 22;365(12):1118-27 - PubMed
  39. PLoS One. 2013 Oct 08;8(10 ):e76830 - PubMed
  40. Br J Surg. 2012 Dec;99(12):1622-9 - PubMed
  41. Lancet. 2012 Nov 24;380(9856):1840-50 - PubMed
  42. Anal Quant Cytol Histol. 2001 Aug;23(4):291-9 - PubMed
  43. J Hepatol. 2012 Apr;56(4):908-43 - PubMed
  44. Transpl Int. 2013 Feb;26(2):109-18 - PubMed

Publication Types

Grant support